Richard D. Truesdell, Jr.

Davis Polk advised Marsh & McLennan Companies, Inc. in connection with its SEC-registered offering of $5 billion aggregate principal amount of its $700 million aggregate principal…

Davis Polk advised the sole initial purchaser in connection with a Rule 144A offering by The Medicines Company of $150 million aggregate principal amount of 3.50% convertible senior…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of $300 million aggregate principal amount of floating-rate notes due 2022, …

Davis Polk advised Tyson Foods, Inc. in connection with its SEC-registered offerings of $900 million aggregate principal amount of senior notes in two series, consisting of $400 million…

Davis Polk advised the underwriter in connection with an SEC-registered secondary offering of 1,500,000 shares of Veritiv Corporation’s common stock by UWW Holdings, LLC. The common stock…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by AbbVie Inc. of $6 billion aggregate principal amount of senior notes in four…

Davis Polk advised the representatives of the several underwriters in connection with Galapagos NV’s offering of 2,961,373 ordinary shares in the form of American depositary shares, which…

Davis Polk advised the representatives of the initial purchasers in connection with an unregistered offering of $20 billion in aggregate principal amount of senior notes by Halfmoon Parent,…

Davis Polk advised the joint book-running managers in connection with the $129.2 million SEC-registered follow-on offering of 2,880,979 shares of Class A common stock of Hamilton Lane…

Davis Polk advised Zai Lab Limited in connection with its first follow-on offering of $150 million of American Depositary Shares representing 7,500,000 ordinary shares of the company. The…